French microbiologist Emmanuelle Charpentier, who was named a co-winner of the second Tang Prize in biopharmaceutical science on Sunday for her work in the development of CRISPR/Cas9, said she hopes the genome editing technology can be used to treat currently incurable conditions.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
-
Science & Tech
Global sustainability summit in Paris features first Taiwan pavilion
03/31/2026 11:48 AM -
Business
U.S. dollar up in Taipei trading
03/31/2026 11:18 AM -
Business
Tainan takes part in U.K. food exhibition, signs cooperation MOU
03/31/2026 11:01 AM -
Society
Sunny weather forecast for most of Taiwan, highs of 36°C possible
03/31/2026 10:15 AM -
Society
Taiwan headline news
03/31/2026 09:49 AM